Safety of anti-IL-23 risankizumab treatment in a patient with severe psoriasis and Charcot-Marie-Tooth disease

被引：0

作者：

Carugno, Andrea ^{[1
,2
]}

Brigenti, Noemi ^{[3
]}

Gisondi, Paolo ^{[3
]}

Al Ghadban, Zeina ^{[4
]}

Parietti, Michele ^{[1
]}

Vezzoli, Pamela ^{[1
]}

Sena, Paolo ^{[1
]}

Pisciotta, Chiara ^{[5
]}

机构：

[1] ASST Papa Giovanni XXIII, Dermatol Unit, Piazza OMS 1, Bergamo, Italy

[2] Univ Milano Bicocca, PhD Program Mol & Translat Med DIMET, Milan, Italy

[3] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy

[4] Univ Milano Bicocca, Sch Med & Surg SMS, Milan, Italy

[5] Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Milan, Italy

来源：

AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2023年 / 64卷 / 04期

关键词：

Charcot-Marie-Tooth; demyelinating neurological disorders; interleukin (IL)-23; psoriasis; risankizumab;

D O I：

10.1111/ajd.14154

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：e376 / e378

页数：3

共 38 条

[1] Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
Haugh, Isabel M.
Preston, Allie K.
Kivelevitch, Dario N.
Menter, Alan M.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3879 - 3883
[2] SAFETY, COMPLICATIONS AND OUTCOMES OF ANAESTHESIA IN CHARCOT-MARIE-TOOTH DISEASE
Bertini, Alessandro
Manganelli, Fiore
Fabrizi, Gian Maria
Schenone, Angelo
Santoro, Lucio
Tagliapietra, Matteo
Cavallaro, Tiziana
Grandis, Marina
Previtali, Stefano Carlo
Falzone, Yuri
Allegri, Isabella
Padua, Luca
Pazzaglia, Costanza
Calabrese, Daniela
Saveri, Paola
Quattrone, Andrea
Valentino, Paola
Tozza, Stefano
Gentile, Luca
Russo, Massimo
Mazzeo, Anna
Vita, Giuseppe
Sommariva, Alberto
Gemma, Marco
Pisciotta, Chiara
Pareyson, Davide
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S8 - S9
[3] Safety of nitrous oxide administration in patients with Charcot-Marie-Tooth disease
Isbister, Geoffrey K.
Burns, Joshua
Prior, Felicity
Ouvrier, Robert A.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 268 (1-2) : 160 - 162
[4] Improvement of Neuropathy Symptoms With Treatment of Obstructive Sleep Apnea in a Patient With Charcot-Marie-Tooth Disease
Polat, Pinar
Pham, Huong
Li, Jun
Bagai, Kanika
JOURNAL OF CLINICAL SLEEP MEDICINE, 2018, 14 (02): : 289 - 291
[5] Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease
Neumann, Y
Toren, A
Rechavi, G
Seifried, B
Shoham, NG
Mandel, M
Kenet, G
Sharon, N
Sadeh, M
Navon, R
MEDICAL AND PEDIATRIC ONCOLOGY, 1996, 26 (04): : 280 - 283
[6] Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease
Pisciotta, Chiara
Pareyson, Davide
NEUROMUSCULAR DISORDERS, 2023, 33 (08) : 627 - 635
[7] Intermittent positive airway pressure by nasal mask as a treatment for respiratory insufficiency in a patient with Charcot-Marie-Tooth disease
Darquennes, K.
De Jonghe, P.
Daems, D.
De Backer, W.
Verbraecken, J.
ACTA CLINICA BELGICA, 2006, 61 (04) : 176 - 181
[8] Coexistence of Charcot-Marie-Tooth disease type 1A and anti-MAG neuropathy
Piscosquito, Giuseppe
Salsano, Ettore
Ciano, Claudia
Palamara, Luisa
Morbin, Michela
Pareyson, Davide
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 (02) : 185 - 188
[9] Patient-specific iPSCs recapitulate the disease signatures of Charcot-Marie-Tooth type 2
Van Lent, Jonas
Juneja, Manisha
Verstraelen, Peter
Asselbergh, Bob
Verbist, Christophe
Timmerman, Vincent
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (04) : 476 - 476
[10] Patient Reported Outcomes Using Medical Cannabis for Managing Pain in Charcot-Marie-Tooth Disease
Canals, Priscilla C.
Aguilar, Alexia G.
Carter, Gregory T.
Shields, C. Miyabe
Westerkamp, Andrew
D'Elia, Meg
Aldrich, Joy
Moore, Robert N.
Moore, Allison T.
Piper, Brian J.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2023, 40 (11) : 1163 - 1167

← 1 2 3 4 →